What Is 3-hydroxyanthranilate oxidase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 3-hydroxyanthranilate oxidase (3-HAO) is an enzyme encoded by the *HMOX2* gene in humans, catalyzing the oxidation of 3-hydroxyanthranilic acid to form 2-amino-3-carboxymuconate semialdehyde, a key step in the kynurenine pathway of tryptophan metabolism.

Key Facts

3-hydroxyanthranilate oxidase is encoded by the HMOX2 gene, identified in 2002
The enzyme catalyzes the conversion of 3-hydroxyanthranilic acid to 2-amino-3-carboxymuconate semialdehyde
It plays a critical role in the kynurenine pathway, which metabolizes ~95% of dietary tryptophan
3-HAO activity generates reactive oxygen species (ROS), contributing to neurotoxicity in high concentrations
Elevated 3-HAO activity is linked to neurodegenerative diseases like Huntington’s and Alzheimer’s

Overview

3-hydroxyanthranilate oxidase (3-HAO) is a critical enzyme in the catabolic breakdown of the essential amino acid tryptophan. It functions within the kynurenine pathway, a metabolic route responsible for processing over 95% of dietary tryptophan that does not go toward protein or serotonin synthesis.

This enzyme specifically targets 3-hydroxyanthranilic acid (3-HAA), converting it into 2-amino-3-carboxymuconate semialdehyde (ACMS). The reaction is oxygen-dependent and produces hydrogen peroxide as a byproduct, linking 3-HAO activity to oxidative stress in cells.

Gene origin: The human gene encoding 3-HAO is HMOX2, first characterized in 2002 as part of heme oxygenase-related research.
Substrate specificity: 3-HAO acts almost exclusively on 3-hydroxyanthranilic acid, with minimal activity on other structurally similar compounds.
Reaction products: The enzyme generates ACMS and hydrogen peroxide, the latter contributing to cellular oxidative stress when accumulated.
Tissue distribution: 3-HAO is expressed at high levels in the liver and brain, particularly in microglia and astrocytes under inflammatory conditions.
Pathway role: It sits at a critical branch point in the kynurenine pathway, directing metabolites toward either neuroprotective or neurotoxic outcomes.

How It Works

The enzymatic mechanism of 3-hydroxyanthranilate oxidase involves molecular oxygen and results in ring cleavage of its substrate. This oxidation reaction is central to the progression of the kynurenine pathway and influences downstream metabolite accumulation.

Enzyme class: 3-HAO is classified as an oxidoreductase, specifically acting on aromatic amino acid derivatives with oxygen as electron acceptor.
Catalytic process: It mediates the dioxygenation of 3-HAA, breaking the benzene ring and forming an unstable intermediate that rearranges into ACMS.
Byproduct formation: The reaction produces hydrogen peroxide (H₂O₂), a reactive oxygen species implicated in neuronal damage when in excess.
pH optimum: The enzyme functions most efficiently at a pH of 7.5 to 8.0, typical of intracellular physiological conditions.
Metabolic fate: ACMS can spontaneously cyclize into quinolinic acid, a known NMDA receptor agonist and excitotoxin.
Regulatory influence: Expression of 3-HAO is upregulated by pro-inflammatory cytokines like IFN-γ and TNF-α during immune activation.

Comparison at a Glance

Below is a comparison of 3-hydroxyanthranilate oxidase with related enzymes in the kynurenine pathway:

Enzyme	Gene	Substrate	Product	Role in Pathway
3-HAO	HMOX2	3-hydroxyanthranilic acid	ACMS	Ring cleavage, ROS generation
KMO	KMO	3-hydroxykynurenine	3-hydroxyanthranilic acid	Produces 3-HAA for 3-HAO
TDO	TDO2	Tryptophan	N-formylkynurenine	Initial rate-limiting step
IDO1	IDO1	Tryptophan	N-formylkynurenine	Immune-regulated initiation
ACMSD	ACMSD	ACMS	Semialdehyde dehydratase product	Diverts from quinolinic acid

This table highlights how 3-HAO fits into the broader kynurenine cascade. Unlike upstream enzymes like TDO or IDO1 that initiate tryptophan breakdown, 3-HAO acts later and directly influences neurotoxic metabolite production. Its activity is tightly balanced by ACMSD, which diverts ACMS away from quinolinic acid formation. Dysregulation at this step is linked to chronic neuroinflammation and neurodegeneration.

Why It Matters

Understanding 3-hydroxyanthranilate oxidase is essential for developing treatments for neurodegenerative and psychiatric disorders. Its role in generating neurotoxic intermediates makes it a key target in disease pathology and drug development.

Neurodegeneration link: Elevated 3-HAO activity correlates with increased quinolinic acid levels in Huntington’s disease and Alzheimer’s pathology.
Oxidative stress: The hydrogen peroxide produced during catalysis contributes to mitochondrial dysfunction and neuronal death.
Therapeutic target: Inhibiting 3-HAO may reduce neurotoxic metabolite accumulation without disrupting essential tryptophan metabolism.
Immune connection: During chronic inflammation, microglial 3-HAO upregulation exacerbates central nervous system damage.
Psychiatric implications: Altered kynurenine pathway activity, including 3-HAO function, is observed in depression and schizophrenia.
Diagnostic potential: 3-HAA and ACMS levels in cerebrospinal fluid may serve as biomarkers for neuroinflammatory conditions.

As research advances, 3-hydroxyanthranilate oxidase continues to emerge as a pivotal enzyme at the intersection of metabolism, immunity, and brain health. Its dual role in normal physiology and disease makes it a compelling focus for future neuroscience and pharmacological studies.